Axel Bex, MD, PhD, from the Netherlands Cancer Institute, Amsterdam, described results of the NeoAvAx trial as ... Dr. Fred Saad describes the results of the PROpel Phase III trial. Dr. Jonathan Rosenberg describes the results of this positive randomized phase 2 trial. Dr Petros Grivas describes the results of this phase 2 trial. Kim Chi, MD, describes the results of the MAGNITUDE trial, Results from the ARASENS trial appear to have confirmed triple therapy as the new standard of care for mHSPC. Pete Nelson, MD, describes mechanism of action and current clinical application in prostate cancer.